- Home
- SO vs GSK Comparison
SO vs GSK Comparison
Compare SO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SO
- GSK
- Stock Information
- Founded
- SO 1946
- GSK 1715
- Country
- SO United States
- GSK United Kingdom
- Employees
- SO N/A
- GSK N/A
- Industry
- SO Power Generation
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- SO Utilities
- GSK Health Care
- Exchange
- SO Nasdaq
- GSK Nasdaq
- Market Cap
- SO 100.1B
- GSK 81.9B
- IPO Year
- SO N/A
- GSK N/A
- Fundamental
- Price
- SO $90.84
- GSK $47.19
- Analyst Decision
- SO Hold
- GSK Buy
- Analyst Count
- SO 16
- GSK 3
- Target Price
- SO $98.66
- GSK N/A
- AVG Volume (30 Days)
- SO 6.3M
- GSK 5.6M
- Earning Date
- SO 10-30-2025
- GSK 10-29-2025
- Dividend Yield
- SO 3.26%
- GSK 3.42%
- EPS Growth
- SO N/A
- GSK 118.57
- EPS
- SO 4.02
- GSK 1.79
- Revenue
- SO $28,913,000,000.00
- GSK $43,237,357,842.00
- Revenue This Year
- SO $9.12
- GSK $6.08
- Revenue Next Year
- SO $4.98
- GSK $5.22
- P/E Ratio
- SO $22.56
- GSK $26.52
- Revenue Growth
- SO 9.40
- GSK 2.73
- 52 Week Low
- SO $80.46
- GSK $31.72
- 52 Week High
- SO $100.84
- GSK $47.37
- Technical
- Relative Strength Index (RSI)
- SO 32.57
- GSK 68.44
- Support Level
- SO $90.50
- GSK $46.39
- Resistance Level
- SO $95.09
- GSK $47.21
- Average True Range (ATR)
- SO 1.54
- GSK 0.78
- MACD
- SO -0.64
- GSK 0.11
- Stochastic Oscillator
- SO 9.63
- GSK 99.78
About SO Southern Company (The)
Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 44 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.